Optimal frontline therapy of chronic myeloid leukemia today, and related musings.

Kantarjian, Hagop M; Begna, Kebede; Jabbour, Elias J; Paul, Shilpa; Welch, Mary Alma; Tefferi, Ayalew

Kantarjian, Hagop M; Begna, Kebede; Jabbour, Elias J; Paul, Shilpa; Welch, Mary Alma; Tefferi, Ayalew.

Afiliación

Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Begna K; Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Paul S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Welch MA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tefferi A; Division of Hematology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Am J Hematol ; 2024 Aug 02.

Article en En | MEDLINE | ID: mdl-39092929

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Hematol Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google